Literature DB >> 28263978

Differing tumor-suppressor functions of Arf and p53 in murine basal cell carcinoma initiation and progression.

G Y Wang1, C N Wood1, J A Dolorito1, E Libove1, E H Epstein1.   

Abstract

Human basal cell carcinomas (BCCs) very frequently carry p53 mutations, and p53 loss markedly accelerates murine BCC carcinogenesis. We report here our studies of the mechanism by which p53 is activated to suppress BCC carcinogenesis. We find that aberrant hedgehog signaling in microscopic BCCs activates p53 in part via Arf (that is, the oncogene-induced stress pathway) but not via the DNA damage response pathway. However, Arf loss and p53 loss produce differing outcomes-loss of p53 promotes both tumor initiation and progression; loss of Arf promotes tumor progression but not initiation. Intriguingly, increased expression of Arf in tumor stromal cells, as in tumor keratinocytes themselves, contributes to suppression of BCC carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28263978     DOI: 10.1038/onc.2017.12

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  47 in total

Review 1.  Divorcing ARF and p53: an unsettled case.

Authors:  Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2006-08-17       Impact factor: 60.716

2.  Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice.

Authors:  M Aszterbaum; J Epstein; A Oro; V Douglas; P E LeBoit; M P Scott; E H Epstein
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

3.  Tumor spectrum in ARF-deficient mice.

Authors:  T Kamijo; S Bodner; E van de Kamp; D H Randle; C J Sherr
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

4.  Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.

Authors:  T Kamijo; E van de Kamp; M J Chong; F Zindy; J A Diehl; C J Sherr; P J McKinnon
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

5.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

6.  Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.

Authors:  P Kanellou; A Zaravinos; M Zioga; D A Spandidos
Journal:  Br J Dermatol       Date:  2009-03-09       Impact factor: 9.302

7.  Patched1 functions as a gatekeeper by promoting cell cycle progression.

Authors:  Christelle Adolphe; Rehan Hetherington; Tammy Ellis; Brandon Wainwright
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

8.  Evasion of p53 and G2/M checkpoints are characteristic of Hh-driven basal cell carcinoma.

Authors:  Z J Li; S C Mack; T H Mak; S Angers; M D Taylor; C-C Hui
Journal:  Oncogene       Date:  2013-06-10       Impact factor: 9.867

9.  Uncoupling cancer mutations reveals critical timing of p53 loss in sarcomagenesis.

Authors:  Nathan P Young; Denise Crowley; Tyler Jacks
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

10.  Establishment of murine basal cell carcinoma allografts: a potential model for preclinical drug testing and for molecular analysis.

Authors:  Grace Ying Wang; Po-Lin So; Lynn Wang; Eileen Libove; Joy Wang; Ervin H Epstein
Journal:  J Invest Dermatol       Date:  2011-08-11       Impact factor: 8.551

View more
  5 in total

1.  Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease.

Authors:  Kenneth G Trieu; Shih-Ying Tsai; Markus Eberl; Virginia Ju; Noah C Ford; Owen J Doane; Jamie K Peterson; Natalia A Veniaminova; Marina Grachtchouk; Paul W Harms; Fredrik J Swartling; Andrzej A Dlugosz; Sunny Y Wong
Journal:  Cell Rep       Date:  2022-05-03       Impact factor: 9.995

Review 2.  The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.

Authors:  Dimakatso Alice Senthebane; Arielle Rowe; Nicholas Ekow Thomford; Hendrina Shipanga; Daniella Munro; Mohammad A M Al Mazeedi; Hashim A M Almazyadi; Karlien Kallmeyer; Collet Dandara; Michael S Pepper; M Iqbal Parker; Kevin Dzobo
Journal:  Int J Mol Sci       Date:  2017-07-21       Impact factor: 5.923

3.  Establishment of basal cell carcinoma animal model in Chinese tree shrew (Tupaia belangeri chinensis).

Authors:  Li-Ping Jiang; Qiu-Shuo Shen; Cui-Ping Yang; Yong-Bin Chen
Journal:  Zool Res       Date:  2017-07-18

4.  Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma.

Authors:  Maria Giovanna Maturo; Sivaramakrishna Rachakonda; Barbara Heidenreich; Cristina Pellegrini; Nalini Srinivas; Celia Requena; Carlos Serra-Guillen; Beatriz Llombart; Onofre Sanmartin; Carlos Guillen; Lucia Di Nardo; Ketty Peris; Maria Concetta Fargnoli; Eduardo Nagore; Rajiv Kumar
Journal:  Sci Rep       Date:  2020-05-14       Impact factor: 4.379

Review 5.  The nucleolus, an ally, and an enemy of cancer cells.

Authors:  Dariusz Stępiński
Journal:  Histochem Cell Biol       Date:  2018-08-13       Impact factor: 4.304

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.